CloSys is testing in a U.S. pivotal trial a vascular closure system designed to meet all the requirements of a $1 billion per year market.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free